Cargando…
Medication-related osteonecrosis of the jaw: knowledge and perceptions of medical professionals on the usage of bone modifying agents and dental referrals
Bone modifying agents (BMA) like bisphosphonates, antiangiogenic, and antiresorptive agents are widely used to manage bone diseases and cancer. Medication-related osteonecrosis of the jaw (MRONJ) is a potentially serious complication seen in patients on BMA therapy. Dental infection is one of the pr...
Autores principales: | Acharya, Shruthi, Patil, Vathsala, Ravindranath, Vineetha, Kudva, Adarsh, Nikhil, Krithi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Carol Davila University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015184/ https://www.ncbi.nlm.nih.gov/pubmed/35449990 http://dx.doi.org/10.25122/jml-2021-0085 |
Ejemplares similares
-
Dental students' knowledge of medication-related osteonecrosis of the jaw
por: Rosella, Daniele, et al.
Publicado: (2017) -
Dental practitioners' and students' knowledge of medication related osteonecrosis of the jaw (MRONJ)
por: Almousa, Mandlin Abdulaziz, et al.
Publicado: (2021) -
Medication-related osteonecrosis of the jaw: An update
por: Bansal, Hitesh
Publicado: (2022) -
Update on Medication Related Osteonecrosis of the Jaws
por: Boyd, Barry C.
Publicado: (2023) -
Medication-related osteonecrosis of the jaw after dental clearance: Prevalence in an oncology center
por: Hajeri, Saad, et al.
Publicado: (2022)